Compare Domino's Pizza, Inc. (DPZ) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Domino's Pizza, Inc. vs Johnson & Johnson — how do they compare? Domino's Pizza, Inc. trades at $353 (market cap $11.82B), while Johnson & Johnson trades at $260.78 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 53× Domino's Pizza, Inc.'s market cap, and Domino's Pizza, Inc. pays the higher dividend (2.23%). Which is the better fit depends on your goals.
| DPZ | JNJ | |
|---|---|---|
Market Cap | $11.82B | $626.09B |
Sector | Consumer Cyclical | Health |
52-Week High | $467.30 | $267.24 |
52-Week Low | $282.89 | $174.16 |
Enterprise Value | $16.78B | $654.37B |
Dividend Yield | 2.23% | 2.06% |
Volume | — | 6,156,228 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DPZ trades at $353.72, up 1.69% today, with a bullish technical signal from moving averages and support at $352. Revenue grew to $4.94B in 2025, with net income of $601.70M, though recent quarters saw EPS misses. The company launched a new individual pizza product in August 2026 to boost sales, as reported by WSJ on August 11, 2026.
Outlook is mixed: analyst consensus is a Buy with a $371.67 target, but high debt and weak Q3 2026 EPS expectations pose risks. Growth depends on new product success and cost management amid competitive pressures.
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Domino's Pizza, Inc.
Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.
Read more on DPZ →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
